Your browser doesn't support javascript.
loading
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.
Jamy, Omer; Innis-Shelton, Raquel; Bal, Susan; Paluri, Ravi; Salzman, Donna; Di Stasi, Antonio; Costa, Luciano; Meredith, Ruby; Lamb, Lawrence; Minagawa, Kentaro; Mineishi, Shin; Saad, Ayman.
Afiliação
  • Jamy O; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Innis-Shelton R; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Bal S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Paluri R; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Salzman D; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Di Stasi A; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Costa L; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Meredith R; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Lamb L; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Minagawa K; Division of Hematology and Oncology, Department of Medicine, Pennsylvania State University, University Park, Pennsylvania, USA.
  • Mineishi S; Division of Hematology and Oncology, Department of Medicine, Pennsylvania State University, University Park, Pennsylvania, USA.
  • Saad A; Division of Hematology and Oncology, Department of Medicine, Ohio State University, Columbus, Ohio, USA.
Am J Hematol ; 96(10): E396-E398, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34288026
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclofosfamida / Transplante de Células-Tronco de Sangue Periférico / Doença Enxerto-Hospedeiro / Imunossupressores Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclofosfamida / Transplante de Células-Tronco de Sangue Periférico / Doença Enxerto-Hospedeiro / Imunossupressores Idioma: En Ano de publicação: 2021 Tipo de documento: Article